Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine.
about
Live attenuated vaccines for invasive Salmonella infectionsComplex adaptive immunity to enteric fevers in humans: lessons learned and the path forwardOptimization of Salmonella enterica serovar typhi DeltaaroC DeltassaV derivatives as vehicles for delivering heterologous antigens by chromosomal integration and in vivo inducible promoters.Regulation of Vi capsular polysaccharide synthesis in Salmonella enterica serotype TyphiExpression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors.Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccinesConstruction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers.Live attenuated S. Typhimurium vaccine with improved safety in immuno-compromised mice.Salmonella Typhimurium TTSS-2 deficient mig-14 mutant shows attenuation in immunocompromised mice and offers protection against wild-type Salmonella Typhimurium infectionVibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity.Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strainSalmonella typhi stimulation of human intestinal epithelial cells induces secretion of epithelial cell-derived interleukin-6.Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system.Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype TyphiEnteric pathogens as vaccine vectors for foreign antigen deliveryIn vitro Intestinal Mucosal Epithelial Responses to Wild-Type Salmonella Typhi and Attenuated Typhoid VaccinesUse of attenuated bacteria as delivery vectors for DNA vaccines.Vaccination against typhoid fever: present statusA sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccinesAttenuating gene expression (AGE) for vaccine developmentRecombinant Salmonella enterica serovar Typhimurium as a vaccine vector for HIV-1 Gag.Typhoid fever & vaccine development: a partially answered question.Challenges in mucosal vaccines for the control of infectious diseases.Characterization of candidate live oral Salmonella typhi vaccine strains harboring defined mutations in aroA, aroC, and htrA.Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans.Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors.Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.Attenuated Bacterial Vaccines
P2860
Q27003066-EB169AFA-24A1-4914-8A5C-86D5F15FF4A0Q27694492-C9F62344-4BD7-4A8F-A87D-95F1E913CC96Q33556968-403BF2CF-4FC9-44A4-9982-D75CFC364959Q33910337-1CBCEC3D-051A-4414-8160-CD5C132D50FBQ34002657-B897AAAF-7C5A-47BA-958B-921B5589ED3AQ34003031-3C844DC9-470A-468E-B7AA-ABAF51702B27Q34003465-53C65056-69A4-4E24-8A26-0457DFFE0085Q34008449-030703E1-D2D7-46A1-89C1-1B1889AA24A0Q34125990-3F43F1D6-705C-4CA9-99E9-946E08213C80Q34429033-0519AC86-0ED9-4064-A465-BCD0B4C36893Q35024060-DF01F092-97EF-4593-BD87-CD145F547A63Q35229428-ADFFC2E4-C55C-4893-AB46-D31EC87C73CCQ35528270-680CDA61-FA8B-4FF4-A262-FF2BDB5D1DA3Q35532132-11FFF3D3-B8C1-4026-822D-1556331486EBQ35534558-17CBC2B7-C108-453A-97DC-CFE3E9B5193CQ35553394-662A9D19-FFB0-4FD9-A900-4716820E147DQ35689430-C78DBEDE-ECF7-4651-83E0-FF0944BF0C0CQ35896020-D5A59307-9D9B-4921-ABF9-419FD9122B53Q36601934-E97A5635-3360-4BD1-B9CF-C75EFA0D733CQ36728805-791ECB94-6B27-4F0F-89FE-89C624FBE06AQ36794750-F18825F2-0A07-4809-BC23-23C5CBE4F5B3Q36950003-E89A0273-2784-4963-9BDC-F0D4FB7D5610Q37021492-8724159B-25E7-4E75-8E33-50597E882908Q37235277-BE01D19B-D182-4FCC-B130-0093C9E89728Q37996843-716D69E6-5AE8-441D-9B9D-11197A5B0523Q38219010-A6430648-E931-420A-A2B6-D184C684502CQ39509638-29C7A0FE-3250-47ED-8411-BF30E689E5FBQ39827320-EAED343E-DDCA-4528-8550-AC7A53983390Q43661617-B8AF05F0-544E-474C-B0F3-9C1A42777380Q46821670-E7B94D1F-3835-446D-99E6-704416FA15F0Q57915185-3B70784B-1284-4DBB-AFA4-1471B5BFB13D
P2860
Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Evaluation in volunteers of a ...... lmonella typhi vector vaccine.
@ast
Evaluation in volunteers of a ...... lmonella typhi vector vaccine.
@en
type
label
Evaluation in volunteers of a ...... lmonella typhi vector vaccine.
@ast
Evaluation in volunteers of a ...... lmonella typhi vector vaccine.
@en
prefLabel
Evaluation in volunteers of a ...... lmonella typhi vector vaccine.
@ast
Evaluation in volunteers of a ...... lmonella typhi vector vaccine.
@en
P2093
P2860
P356
P1476
Evaluation in volunteers of a ...... lmonella typhi vector vaccine.
@en
P2093
P2860
P304
P356
10.1172/JCI115876
P407
P577
1992-08-01T00:00:00Z